TNF and rheumatoid arthritis: Compared to neighboring countries in the region with higher national gross domestic product (GDP) per capita, such as Saudi Arabia and the United Arab Emirates, Jordanian patients with RA were found to have a significantly higher usage of GCs and substantially lower use of tumor necrosis factor (TNF) inhibitors and methotrexate [12].